FDA Approves First Treatment for Nonradiographic Axial Spondyloarthritis - Rheumatology Advisor
FDA Approves First Treatment for Nonradiographic Axial Spondyloarthritis Rheumatology Advisor
The Food and Drug Administration (FDA) has approved Cimzia (certolizumab pegol; UCB) injection for the treatment of adults with nonradiographic axial ...
Comments
Post a Comment